Corindus Vascular Robotics, Inc. CVRS Income Statement

Corindus vascular robotics, inc. (CVRS)

Income statement / Quarterly

Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Revenue
-	-	-	-	-	-	-	-	-	-	538	688	508	1,108	832	212	909	776	622	554	1,077	730	-	27	9	-	-	-	-	-	-	-	-
Revenue
4,575	3,036	4,673	2,958	1,665	1,485	4,190	2,425	2,258	777	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-	65	54	32	22	52	53	42	2
Cost of revenue
2,778	2,414	2,759	1,834	2,151	1,929	2,990	2,183	2,200	1,892	1,630	1,220	1,114	1,078	1,260	722	941	801	-	793	-	4	5	19	28	67	62	39	42	42	40	37	3
Cost of revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,058	1,383	-	315	-	-	-	-	-	-	-	-	-
Gross profit (loss)
1,797	622	1,914	1,124	-486	-444	1,200	242	58	-1,115	-1,092	-532	-606	30	-428	-510	-32	-25	-1,048	-239	19	-653	-1	-288	-19	-1	-8	-7	-19	-	-	-	-
Operating expenses:
Research and development
3,719	2,876	2,599	2,035	2,000	2,135	1,971	2,493	2,489	2,564	2,940	2,728	2,335	2,310	2,182	2,263	2,825	2,763	1,751	1,352	1,458	2,046	-	1,525	-	-	-	-	-	-	-	-	-
Selling, general and administrative
8,373	7,147	6,603	6,368	6,874	7,455	7,211	5,588	5,906	6,072	5,577	4,585	4,437	4,965	4,260	3,885	4,014	3,984	3,548	3,796	2,848	2,810	-	-	-	-	-	-	-	-	-	-	-
Compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	2	2	2	2	2	2	2	2	2	1
Consulting fees - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36	-	-	-	0	12	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-668	7	656	79	35	14	18	23	29	16	23	1
Sales and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,332	-	-	-	-	-	-	-	-	-
Restructuring charge
-	-	-	-	349	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	82	93	-	0	-	-	-	-	-	-	-	-	-
Total operating expense
12,092	10,023	9,199	8,403	9,223	9,590	9,182	8,081	8,395	8,636	8,517	7,313	6,772	7,275	6,442	6,148	6,839	6,747	5,299	5,148	4,388	4,949	46	3,513	81	73	17	33	25	74	59	63	6
Operating loss
-10,295	-9,401	-7,285	-7,279	-9,709	-10,034	-7,982	-7,839	-8,337	-9,751	-9,609	-7,845	-7,378	-7,245	-6,870	-6,658	-6,871	-6,772	-6,347	-5,387	-4,369	-5,602	-47	-3,801	-101	-75	-25	-40	-45	-21	-5	-20	-4
Other income (expense)
Interest expense
556	-	-	-	383	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	3	8	0	2	0	0	0	0	0	0	0
Interest income
192	-	-	-	66	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant revaluation
-	-	80	-60	70	30	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest, net
-	-270	-	-256	-	-44	17	-14	-77	-134	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other, net
-	-6	-	-	-	-2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant revaluation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,884	-1,302	1,765	-	0	-	-	-	-	-	-	-	-	-
Other, net
-2	-276	-397	-316	47	-16	11	-14	-77	-134	-182	-221	-216	-382	-359	-404	-432	-397	-	-178	-39	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	10	-	-	-	-	-	-	-	-	-
Total other income (expense), net
-366	-	-	-	-200	-	-	-	-	-	-	-	-	-	-	-404	-432	-397	-201	-3,062	-1,341	1,768	-	10	-	-	-	-	-	-	-	-	-
Other (income) expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-	2	0	0	0	-	-	-	-
Loss before income tax provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-53	-51	-59	-101	-78	-25	-40	-46	-21	-5	-20	-4
Income tax provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	0	0	0	0	0
Net loss
-10,661	-9,677	-7,435	-7,595	-9,909	-10,050	-7,971	-7,853	-8,414	-9,885	-9,791	-8,066	-7,594	-7,627	-7,229	-7,062	-7,303	-7,169	-6,548	-8,449	-5,710	-3,834	-51	-3,791	-101	-78	-25	-40	-46	-21	-5	-20	-4
Accretion of beneficial conversion feature of Series A and Series A-1 preferred stock
510	-	-30	0	0	5,236	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends on preferred stock
751	747	-752	758	753	125	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of Series A-1 preferred stock as dividends on Series A preferred stock
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-11,922	-10,424	-8,217	-8,353	-10,662	-15,411	-7,971	-7,853	-8,414	-9,885	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common stockholders--basic and diluted (in dollars per share)
-	-0.05	-	-0.04	-	-0.08	-0.05	-0.04	-0.04	-0.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)
-	196,691	-	189,377	-	188,771	189,330	187,301	187,190	131,880	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributed to common stockholders--basic and diluted (in dollars per share)
-0.06	-	-	-	-0.06	-	-	-	-	-	-0.09	-0.07	-0.06	-0.06	-0.05	-0.06	-0.07	-0.07	-0.06	-0.10	-0.08	-0.05	0.00	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)
207,121	-	-	-	188,833	-	-	-	-	-	119,024	118,958	119,049	119,046	118,819	118,541	109,775	105,883	106,262	86,977	73,360	73,360	-	73,360	52,000	-	-	-	-	-	-	-	-
Net loss
-10,661	-9,677	-7,435	-7,595	-9,909	-10,050	-7,971	-7,853	-8,414	-9,885	-9,791	-8,066	-7,594	-7,627	-7,229	-7,062	-7,303	-7,169	-6,548	-8,449	-5,710	-3,834	-51	-3,791	-101	-78	-25	-40	-46	-21	-5	-20	-4
Unrealized gain (loss) on marketable securities
-	-	-	-	-	-	-	-	-	-	0	-9	5	18	-	-7	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
-10,661	-9,677	-7,435	-7,595	-9,909	-10,050	-7,971	-7,853	-8,414	-9,885	-9,791	-8,075	-7,589	-7,609	-7,236	-7,069	-7,303	-7,169	-	-8,449	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52,000	-	-	-	52,000	52,000	52,000	65,592	52,000	31,267	0